Part B CAP Fix Could Take Creative Thinking, But Law Limits Flexibility
Executive Summary
Figuring out how the Medicare Part B competitive acquisition program can be made more attractive for specialty drug distributors within the confines of the statute could be a tall order for CMS
You may also be interested in...
CMS Suspends Part B CAP As Vendors Avoid Program; Overhaul May Follow
The competitive acquisition program for Medicare Part B drugs and biologics will be put on hold in 2009 because of a lack of interest among specialty drug distributors in becoming approved vendors
CMS Proposes Lifting CAP’s Ban On Physicians Transporting Part B Drugs
CMS is proposing to do away with its restriction against physicians transporting from one location to another the drug products obtained through Medicare Part B's competitive acquisition program
GSK's Nucala Is Significantly Overpriced, ICER Draft Report Finds
New biologic for severe asthma doesn't stack up well to standard of care on generally accepted levels of cost per quality-adjusted life year.